Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials - Wikidata - wikimedia - TriplyDB

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

http://www.wikidata.org/entity/Q22241828

about

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Negativland - a home for all findings in psychology Lysergic acid diethylamide: a drug of 'use'?Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Legal highs: staying on top of the flood of novel psychoactive substances Illegal drugs laws: clearing a 50-year-old obstacle to research Psychedelics LSD-induced entropic brain activity predicts subsequent personality change.Modern Clinical Research on LSD.Alterations of consciousness and mystical-type experiences after acute LSD in humans.How Drug Control Policy and Practice Undermine Access to Controlled Medicines.Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.The Heffter Research Institute: past and hopeful future.Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Psychedelic medicine: a re-emerging therapeutic paradigm.Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Clinical applications of hallucinogens: A review.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses.Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca.The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.Potential Therapeutic Effects of Psilocybin.Therapeutic Applications of Classic Hallucinogens.Mind-altering drugs and research: from presumptive prejudice to a Neuroscientific Enlightenment?: Science & Society series on "Drugs and Science"Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.Psilocybin for treating substance use disorders?An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.Psychedelics as Medicines: An Emerging New Paradigm.Back to the future: a return to psychedelic treatment models for addiction.The Effects of Hallucinogens on Gene Expression.Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience.Long-term follow-up of psilocybin-facilitated smoking cessation.

P2860

Q21129387-13553156-B491-4FB9-B53A-94D8399B1EE1 Q24288901-B5EE9554-6459-47EE-98BC-11CED815452F Q26746133-DCF1EB6B-9FB2-4EE4-84CC-E267CA05068F Q26746137-4446E947-FD6B-4531-8E0B-06B0A0DAB5C5 Q26799231-4A9D2616-7D81-44B3-AC12-E77CDDF2DD7B Q28543098-94375224-93A0-4743-B0C9-55509CE85746 Q30359998-860D941A-C83F-463F-A036-EBE01F791676 Q30387757-2353993D-19F1-42D3-8AF0-BAE7EEB336CB Q30401421-3ED5C1B6-6FA7-40A0-BD5D-1D5974D00692 Q30847957-2D41DF70-4947-4DE5-93F8-6B4CB548B533 Q33805755-6F294838-677B-490C-895A-12EF75C4B20A Q33937677-F608E2FB-8D73-4245-964F-48B01AF8F8F6 Q34040967-F58BA898-BEC8-4B3A-BAC1-AE3E275B0DAF Q34396223-0E998739-147A-4897-A603-5E5240D69C13 Q34438146-1EB6B727-A0DE-455B-A085-6FE2515B02C1 Q34493217-DA78DE18-0B0E-4F17-9D40-386B3694DEDD Q34497649-8E982F56-082E-4817-93D7-43636847C318 Q34535259-666106FE-2873-4786-A48A-28046EA5254F Q34546304-25A1770E-D06D-467A-AC8D-99D4837E594B Q35126018-40480AE8-A4D7-49CD-BDE3-729874C071ED Q37052393-2A4036CD-A91A-4619-BCDC-20C61C326660 Q37722650-84532DEF-95C4-4B29-A400-6818AA22BE51 Q38023813-58D02F8A-561F-4CC9-985E-55010A749173 Q38061522-D87D92FF-53DB-48AC-B9D1-06D858D4527B Q38211889-6C179286-B42E-49A8-91BE-A682D11E7E93 Q38351502-6D642731-9D73-4FA7-B319-B8251AFC1CB7 Q38636031-2250FF31-908D-48FA-885B-2FD7BBB48EB3 Q38690821-1EDBC5C9-8A36-472C-BDE6-FD4822F7ED1D Q38741517-40EBC8A5-6C63-4D48-977A-1E4723CC0A53 Q38781678-E4F2BEFE-A509-4677-8A93-609B423E1EAF Q38798504-C5C2EC5E-3A17-418E-B077-3819D5320110 Q38961114-6485CE58-EB4F-4D60-91D6-3C67867CCB47 Q38967632-972CCEBB-00E2-4346-9D59-623501476063 Q39016513-8633C934-8000-4801-8250-B3D4036CD345 Q39055247-30252625-5409-4559-BB93-02356D869168 Q39123721-EACA26A0-633E-40C5-B8B0-A8D5B2A762F9 Q39414457-ECF94238-87E8-4B0E-A765-9D1CD733EB7A Q39414464-319F6B9D-8F14-4FE1-B0D3-6BFD4544BC36 Q39546691-3998E198-9526-4EC5-8062-8BA7ABC03893 Q39577435-E405FAB2-7B8A-4512-9F0F-430D7E8FEF1A

P2860

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

http://www.wikidata.org/entity/Q22241828

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@ast

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@en

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@nl

type

label

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@ast

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@en

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@nl

prefLabel

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@ast

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@en

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@nl

P1433

Q22241828-244A8680-12CC-4683-85FD-92CF4435EFBE

P1476

Q22241828-A617D518-F103-4A75-8328-BEEC2E62367A

P2093

Q22241828-3D96730E-3101-46B8-BC9F-6D8AA2FCB8EC

Q22241828-7E242CDD-BB1B-4F2A-BE07-10F8C6A2CCF0

P2860

Q22241828-0526C210-9B5A-4A44-9872-12E9B532EE4A

Q22241828-0A597CC8-83DE-458B-9FB2-73CB7181F78F

Q22241828-0A9A3D13-9D47-4DB3-943F-1AF10414E235

Q22241828-20C5568C-9D84-4485-98A9-7CD7847DCB1B

Q22241828-375D6A5E-3BA5-43F7-AB59-7BE4F0EC9972

Q22241828-3894FB6C-1346-4307-8F9B-4CEBE677DE87

Q22241828-5D07B0E4-2950-42B7-83F6-AF27EFA18452

Q22241828-6EC292A3-8F2E-4F2E-9810-ACEE51D0D9BA

Q22241828-7A7A0805-1ACF-439D-8CFA-0685204E3871

Q22241828-7A7AE091-6BB3-4809-9DCB-DB74078C6964

P304

Q22241828-75F35A68-AF54-483C-95FF-C36EC332728B

P31

Q22241828-691C0F71-E2C4-4E94-B21E-8D297E3FC2A4

Q22241828-855EE4D4-F783-43B3-A699-8D731433C135

P3181

Q22241828-32BB73DD-D8E6-43EC-AD0A-CF8DBA1C2EDF

P356

Q22241828-DA32CE3D-2EAA-4F92-9A02-28B2BF01F6C9

P407

Q22241828-4187BF5F-B632-46AB-80A5-28467A7CDDF0

P433

Q22241828-7C9E2976-59C3-4EA8-A113-4553D5A4DCFE

P478

Q22241828-8A18D4D4-3D79-4E0C-BDA5-E6CFE4BC4FB8

P577

Q22241828-99A51157-B08E-40B3-BB0F-CC80EBAD1FB1

P5875

Q22241828-6A841645-D020-4D33-A2A9-13F842429173

P698

Q22241828-DF15D516-E65C-4BAA-9F8A-E3561D0575F8

P921

Q22241828-44F9362F-4EB2-49FB-BCB9-C3C3629F5408

Q22241828-68C7B5B4-C3CF-45FF-A338-B80B01825449

P3181

P356

0269881112439253

P1433

Journal of Psychopharmacology

P1476

Lysergic acid diethylamide (LS ...... f randomized controlled trials

@en

P2093

P.-O. Johansen

http://www.w3.org/2001/XMLSchema#string

T. S. Krebs

http://www.w3.org/2001/XMLSchema#string

P2860

The pharmacology of lysergic acid diethylamide: a review.

Human hallucinogen research: guidelines for safety

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.

Drug harms in the UK: a multicriteria decision analysis.

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.

A clinical study of LSD treatment in alcoholism.

Treatment of alcoholism using psychedelic drugs: a review of the program of research.

Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment.

P304

994-1002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4546108

http://www.w3.org/2001/XMLSchema#string

P356

10.1177/0269881112439253

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221692919

http://www.w3.org/2001/XMLSchema#string

P698

22406913

http://www.w3.org/2001/XMLSchema#string

P921